Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 344 followers
Latest posts
Last updated about 13 hours ago
Mayo Clinic teams with Thermo Fisher to form biomedical data group Precure
about 13 hours ago
The Mayo Clinic has partnered with Thermo Fisher Scientific to launch a...
FDA launches pilot program to speed up sluggish phase 1 trials
about 13 hours ago
After teasing a new initiative to speed up early-stage clinical trials over...
Newly formed Jaguar acquires Afib device assets from J&J
about 14 hours ago
Jaguar LAA, a newly formed medtech, has acquired assets that are part...
Connect's Dupixent rival flunks phase 2 asthma trial, but biotech sees reasons for hope
about 17 hours ago
Connect Biopharma’s hopes of dethroning Dupixent took a knock as its IL-4/IL-13...
Lilly pledges up to $237M per program in CNS genetic med collab with Canadian biotech
about 17 hours ago
Eli Lilly’s ongoing attempt to strengthen its genetic medicine offering has seen...
Sionna lays off 46% of workforce in strategic shift after cystic fibrosis trial fail
about 17 hours ago
Sionna Therapeutics is laying off almost half its workforce as the company...
After rejection, FDA approves Telix’s Pixclara, the first FET-PET imaging drug for brain cancer
about 20 hours ago
The FDA has signed off on the first ever glioma drug imaging...
GSK doubles down on Chimagen with $750M multiple myeloma wager
about 20 hours ago
GSK has bet up to $750 million on a Chimagen Biosciences trispecific...
Novo walks away from $285M pact to develop monthly GLP-1 obesity drug with Ascendis
about 22 hours ago
Novo’s attempted rebrand got off to a shaky start this week with...
J&J’s Contineum-partnered depression drug flunks another phase 2 test
about 23 hours ago
A phase 2 trial of Johnson & Johnson’s JNJ-5120 has missed its...
Axoltis misses the mark in phase 2 ALS study, but still strives to move towards the clinic
1 day ago
Axoltis Pharma announced today that its phase 2 trial for amyotrophic lateral...
Owkin, Servier ink oncology R&D deal to guide discovery and trial design
1 day ago
AI drug discovery company Owkin has signed a pact with French drugmaker...